Search results
Results from the WOW.Com Content Network
The origins of Galderma date back to 1961 and the founding of the Owen dermatology company in Dallas, Texas, USA by M. Owen. [5]. In 1979, Professor Hans Schaefer founded the International Center for Dermatological Research (CIRD) in Sophia Antipolis, with the support of the CEO of L'Oréal, François Dalle, who wanted to diversify his cosmetic research into the drug sector.
That year, Nestlé spent about $350 million on dermatology research and development. The first of the research hubs, Nestlé Skin Health Investigation, Education and Longevity Development (SHIELD) centres, will open mid 2015 in New York, followed by Hong Kong and São Paulo, and later others in North America, Asia, and Europe.
The New York City Economic Development Corporation's Early Stage Life Sciences Funding Initiative and venture capital partners, including Celgene, General Electric Ventures, and Eli Lilly, committed a minimum of US$100 million to help launch 15 to 20 ventures in life sciences and biotechnology in 2014, [6] and in January 2018, the City of New ...
Fredric Sheldon Brandt (June 26, 1949 – April 5, 2015) was an American physician, researcher, lecturer, author, and radio host specializing in cosmetic dermatology. Among the first to use botulinum toxin ("botox") and fillers, [ 1 ] Brandt was noted for his role in the FDA approval of numerous fillers and botulinum toxins for cosmetic use in ...
According to The New York Times, the label lists mild side effects like urinary tract and skin infections, but now that might have to be expanded to more serious health risks.. Related: First FDA ...
On the local level, Reason Foundation found that New York City had over $300 billion in total liabilities at the end of 2022, more than four times Chicago’s $74 billion in liabilities and nearly ...
Vivek Ramaswamy speaks during a rally for Republican presidential nominee and former U.S. President Donald Trump at Madison Square Garden, in New York City, Oct. 27, 2024. (Andrew Kelly/Reuters)
Global headquarters, Research Triangle Park, North Carolina. Stiefel Laboratories Inc. is an American dermatological pharmaceutical company, with its global headquarters in Research Triangle Park, North Carolina. [1] It makes products such as Duac and Oilatum. [2] Stiefel was acquired by GSK plc at a price of $2.9 billion.